Skip to content
10-Q

Quarterly Report

STRONGBRIDGE BIOPHARMA plc

0001558370-21-010406

← back to feed
Filed
Aug 5, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Aug 2, 2021 67.83M sh
Shares Diluted Q2 2021 · Jun 30, 2021 67.92M sh
Shares Diluted Q2 2021 · Jun 30, 2021 67.57M sh
Shares Diluted Q2 2021 · Jun 30, 2020 54.3M sh
Shares Diluted Q2 2021 · Jun 30, 2020 54.27M sh
Capex Q2 2021 · Jun 30, 2021 $10K
Operating Cash Flow Q2 2021 · Jun 30, 2021 −$23.22M
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$27.38M
Long Term Debt Q2 2021 · Jun 30, 2021 $17M
Long Term Debt Q2 2021 · Dec 31, 2020 $17.11M
Short Term Debt Q2 2021 · Jun 30, 2021 $708K
Cash And Equivalents Q2 2021 · Jun 30, 2021 $63.77M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $87.52M
Stockholders Equity Q2 2021 · Jun 30, 2021 $44.39M
Stockholders Equity Q2 2021 · Mar 31, 2021 $55.85M
Stockholders Equity Q2 2021 · Dec 31, 2020 $65.61M
Stockholders Equity Q2 2021 · Jun 30, 2020 $47.87M
Stockholders Equity Q2 2021 · Mar 31, 2020 $61.18M
Stockholders Equity Q2 2021 · Dec 31, 2019 $72.19M
Current Liabilities Q2 2021 · Jun 30, 2021 $23.38M
Current Liabilities Q2 2021 · Dec 31, 2020 $21.13M
Total Liabilities Q2 2021 · Jun 30, 2021 $52.43M
Total Liabilities Q2 2021 · Dec 31, 2020 $55.5M
Current Assets Q2 2021 · Jun 30, 2021 $70.12M
Current Assets Q2 2021 · Dec 31, 2020 $92.35M
Total Assets Q2 2021 · Jun 30, 2021 $96.82M
Total Assets Q2 2021 · Dec 31, 2020 $121.1M
Eps Diluted Q2 2021 · Jun 30, 2021 −$0.21
Eps Diluted Q2 2021 · Jun 30, 2021 −$0.37
Eps Diluted Q2 2021 · Jun 30, 2020 −$0.32
Eps Diluted Q2 2021 · Jun 30, 2020 −$0.55
Eps Basic Q2 2021 · Jun 30, 2021 −$0.20
Eps Basic Q2 2021 · Jun 30, 2021 −$0.37
Eps Basic Q2 2021 · Jun 30, 2020 −$0.32
Eps Basic Q2 2021 · Jun 30, 2020 −$0.55
Sga Expense Q2 2021 · Jun 30, 2021 $15.99M
Sga Expense Q2 2021 · Jun 30, 2021 $26.93M
Sga Expense Q2 2021 · Jun 30, 2020 $9.64M
Sga Expense Q2 2021 · Jun 30, 2020 $20.04M
Rd Expense Q2 2021 · Jun 30, 2021 $5.4M
Rd Expense Q2 2021 · Jun 30, 2021 $11.24M
Rd Expense Q2 2021 · Jun 30, 2020 $6.15M
Rd Expense Q2 2021 · Jun 30, 2020 $13.7M
Net Income Q2 2021 · Jun 30, 2021 −$13.24M
Net Income Q2 2021 · Jun 30, 2021 −$25.06M
Net Income Q2 2021 · Jun 30, 2020 −$17.27M
Net Income Q2 2021 · Jun 30, 2020 −$29.97M
Operating Income Q2 2021 · Jun 30, 2021 −$13.07M
Operating Income Q2 2021 · Jun 30, 2021 −$23.13M
Operating Income Q2 2021 · Jun 30, 2020 −$9.68M
Operating Income Q2 2021 · Jun 30, 2020 −$23.18M
Revenue Q2 2021 · Jun 30, 2021 $10.04M
Revenue Q2 2021 · Jun 30, 2021 $18.42M
Revenue Q2 2021 · Jun 30, 2020 $7.76M
Revenue Q2 2021 · Jun 30, 2020 $14.43M